Incisive Health
Warning! As of 20 September 2021, the EU lobby register has changed format. Temporarily, the register is no longer providing daily data updates of all lobby data which means that the figures on LobbyFacts cannot currently be kept up-to-date. If, for example, you see a company, trade association, or lobby consultancy with "no figure available" for EU lobby costs, open the data card, and click the link to the EU lobby register where you will find the updated registration including EU lobby costs declaration. Regretably, under the lobby register format, NGOs and think tanks are no longer required to provide a figure for EU lobby costs. We will update LobbyFacts with the new data as soon as possible.
Lobbying costs:
WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.
WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.
No figure available
Lobbyists declared: 8.25 FTE (9)
WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.
Lobbyists with EP accreditation: 0
Meetings with European Commission: 1
Lobbying costs over the years:
Incisive Health
Registration on EU Transparency Register
Website
Goals / Remit
Incisive Health is a leading force in health policy and communications. In a healthcare environment that is noisy, changing rapidly and where decision-makers are under intense pressure, policy communications need to be incisive to make an impact.
Our work in Brussels focuses on supporting pan-European healthcare campaigns, engaging in Europe-wide clinical advocacy and leading policy communications in areas of EU competence.
Our team is made up of people with extensive experience of the European Commission and the European Parliament, and has a close knowledge of the EU regulatory landscape and how it impacts on healthcare delivery in EU member states.
We know how to cut through the noise and competing priorities to deliver results that enhance our clients' businesses and reputations and – ultimately – improve healthcare for patients.
Issues
Incisive Health provides strategic advice on EU policy developments and on engagement with the EU policymaking process in the public health field. We also support pan-European campaigns to improve patient care across EU member states. Our focus is on healthcare and public health matters in the EU regulatory environment and other issues - such as those affecting the economy, enterprise, information, the internal market, research and technology, and trade - to the extent that they impact these matters. As such, we work with EU policymakers on topics such as access to medicines, pharmaceutical policy, cross-border healthcare, patients’ rights and safety, digital health, market access issues, intellectual property rights, health funding, innovation, research and development in health, the impact of other EU policies on health. Incisive health works on EU policies related to healthcare and public health matters including on initiatives and legislative files on the following topics: - access to medicines, - pharmaceutical policy, - cross-border healthcare, - patients’ rights and safety, - digital health, - market access issues, - intellectual property rights, - health funding, - innovation, research and development in health, - the impact of other EU policies on health.
Address
51 Welbeck Street
London W1G 9HL
United Kingdom
Tel: 44 02034356100